Lymph-node relapsed prostate cancer management and PET-driven external beam radiotherapy: Salvage or palliative treatment?

V. Vavassori, F. Alongi, G. A. D'Agostino, E. Della Bosca, M. Scorsetti

Research output: Contribution to journalArticlepeer-review

Abstract

New imaging modalities such as choline-positron emission tomography (PET) or PET/computed tomography (CT) may be useful to identify prostate cancer patients with small volume, limited nodal relapse ("oligo-recurrent"), potentially amenable to metastasis directed treatment (e.g. radiotherapy,) with the aim of long-term control of the disease, even in a setting traditionally considered prognostically unfavorable, so usually gone to palliative treatment. This report reviews the diagnostic tools and the main published data about the role of PET or PET/CT driven radiation therapy, (not only for the diagnosis, but also for the plannig) in relapsed node prostate carcinoma, as an alternative therapeutic strategy than surgery or androgen deprivation therapy.

Original languageEnglish
Pages (from-to)411-419
Number of pages9
JournalQuarterly Journal of Nuclear Medicine and Molecular Imaging
Volume59
Issue number4
Publication statusPublished - Dec 1 2015

Keywords

  • Diagnostic imaging
  • Prostatic neoplasms
  • Radiotherapy
  • Recurrence

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint

Dive into the research topics of 'Lymph-node relapsed prostate cancer management and PET-driven external beam radiotherapy: Salvage or palliative treatment?'. Together they form a unique fingerprint.

Cite this